- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Positioning of proteasome inhibitors in therapy of solid malignancies ; volume:81 ; number:2 ; day:28 ; month:11 ; year:2017 ; pages:227-243 ; date:2.2018
Cancer chemotherapy and pharmacology ; 81, Heft 2 (28.11.2017), 227-243, 2.2018
- Keyword
-
Krebs
Onkologie
- Creator
-
Roeten, Margot S. F.
- Contributor
-
Cloos, Jacqueline
Jansen, Gerrit
SpringerLink (Online service)
- DOI
-
10.1007/s00280-017-3489-0
- URN
-
urn:nbn:de:1111-201803215785
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roeten, Margot S. F.
- Cloos, Jacqueline
- Jansen, Gerrit
- SpringerLink (Online service)
Other Objects (12)
Proteasome inhibitors against amelanotic melanoma
Gastrointestinal toxicities of proteasome inhibitor therapy
Checkpoint inhibitors in hematological malignancies
Characterisation and optimisation of 20S proteasome inhibitors
Characterisation and optimisation of 20S proteasome inhibitors
Targeting hypoxia in solid and haematological malignancies
Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
BU-32: a novel proteasome inhibitor for breast cancer
Patented small molecule inhibitors in the ubiquitin proteasome system
Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor
Proteasome inhibitors against amelanotic melanoma
Gastrointestinal toxicities of proteasome inhibitor therapy
Checkpoint inhibitors in hematological malignancies
Characterisation and optimisation of 20S proteasome inhibitors
Characterisation and optimisation of 20S proteasome inhibitors
Targeting hypoxia in solid and haematological malignancies
Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
BU-32: a novel proteasome inhibitor for breast cancer
Patented small molecule inhibitors in the ubiquitin proteasome system
Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor
Proteasome inhibitors against amelanotic melanoma
Gastrointestinal toxicities of proteasome inhibitor therapy
Checkpoint inhibitors in hematological malignancies
Characterisation and optimisation of 20S proteasome inhibitors
Characterisation and optimisation of 20S proteasome inhibitors
Targeting hypoxia in solid and haematological malignancies
Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
BU-32: a novel proteasome inhibitor for breast cancer
Patented small molecule inhibitors in the ubiquitin proteasome system